The recent exponential decline in the cost of sequencing human genomes to within an order of magnitude of $1000 has led to increased use of this technology in a variety of research and clinical settings. Examples of clinical sequencing success stories for diagnosing rare conditions are increasingly common and sequencing of tumor samples is being performed in many academic cancer centers to help guide care.1 To date, whole-genome or exome (the protein-coding portions of the genome) sequencing is not a tool being applied to large populations of individuals, but another major decrease in cost may make such testing available to substantial segments of the population. Federally funded exploration of sequencing as an adjunct to routine newborn screening is already underway, and private sector companies are developing expanded carrier screening tests for the purpose of reproductive decision making.2,3 These developments suggest that in the future, genomic sequence data may become a routine component of clinical diagnosis, risk assessment, prevention, and drug selection.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Care at the Close of Life EDUCATION GUIDES
The Role of Chemotherapy at the End of Life
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.